US FDA Adcomm Modernization Includes How Meetings Are Scheduled

 
• By Derrick Gingery

Agency officials are considering developing policies for when an advisory committee meeting is appropriate, in part because of the workload associated with them. Could fewer meetings result?

Scheduling notebook
Advisory committee scheduling is difficult, which is prompting the FDA to update policies on when the meetings are appropriate. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers